Osaic Holdings’s Lexaria Bioscience LEXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$371 Sell
119
-27
-18% -$205 ﹤0.01% 7773
2026
Q2
$1.23K Buy
146
+106
+265% +$1.15K ﹤0.01% 7427
2026
Q1
$471 Sell
40
-106
-73% -$1.15K ﹤0.01% 7449
2025
Q4
$1.36K Hold
146
– – ﹤0.01% 7191
2025
Q3
$2.12K Hold
146
– – ﹤0.01% 7122
2025
Q2
$1.9K Buy
146
+20
+16% +$344 ﹤0.01% 6948
2025
Q1
$3.23K Sell
126
-27
-18% -$687 ﹤0.01% 6402
2024
Q4
$4.81K Hold
153
– – ﹤0.01% 6222
2024
Q3
$6.98K Hold
153
– – ﹤0.01% 6042
2024
Q2
$6.37K Buy
153
+7
+5% +$315 ﹤0.01% 6048
2024
Q1
$7.95K Buy
146
+116
+387% +$4.43K ﹤0.01% 5876
2023
Q4
$588 Sell
30
-13
-30% -$251 ﹤0.01% 6868
2023
Q3
$649 Sell
43
-93
-68% -$1.27K ﹤0.01% 6937
2023
Q2
$1.49K Hold
136
– – ﹤0.01% 6756
2023
Q1
$5.56K Hold
136
– – ﹤0.01% 6276
2022
Q4
$5K Hold
136
– – ﹤0.01% 6283
2022
Q3
$5K Hold
136
– – ﹤0.01% 6366
2022
Q2
$7K Hold
136
– – ﹤0.01% 6311
2022
Q1
$7K Hold
136
– – ﹤0.01% 6330
2021
Q4
$8K Buy
136
+111
+444% +$9.48K ﹤0.01% 6400
2021
Q3
$2K Buy
25
+14
+127% +$1.34K ﹤0.01% 6866
2021
Q2
$1K Hold
11
– – ﹤0.01% 6861
2021
Q1
$1K Buy
+11
New +$967 ﹤0.01% 6667

Other funds holding LEXX

Osaic Holdings's LEXX Position: Q3 2026 in Review

Osaic Holdings reduced its Lexaria Bioscience (LEXX) stake by 18% in Q3 2026, selling an estimated $205 and leaving 119 shares worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #7773.

Osaic Holdings first reported a position in LEXX in Q1 2021 and has held it in 23 quarters since. The position peaked at $8K in Q4 2021. 15 funds tracked by Wall St. Rank hold LEXX as of Q3 2026.

  • Osaic Holdings held 119 shares of Lexaria Bioscience worth $371 as of Q3 2026.
  • Osaic Holdings sold 27 Lexaria Bioscience shares in Q3 2026, an estimated $205.
  • Lexaria Bioscience made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7773 holding.
  • Osaic Holdings first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 23 quarters since.
  • Osaic Holdings's Lexaria Bioscience position peaked at $8K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.